Ulf Wiinberg, Director of MiNK Therapeutics INKT, has filed 1 purchase and 0 sales on the open market. The latest trade was on 06/01.

UW

UW

Ulf Wiinberg

Director

Company

MiNK Therapeutics INKT

First filing

23/01/04

Trades

28 trades

Buys / sales

1 / 0

12-month net buying

No record

Last trade

06/01

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
AgenusAGEN	Open-market buy	23/11/15	23/11/17	25,000 sh	$0.76	$19,000	+25.2%